These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12454457)

  • 1. Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370.
    Asojo OA; Afonina E; Gulnik SV; Yu B; Erickson JW; Randad R; Medjahed D; Silva AM
    Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2001-8. PubMed ID: 12454457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum.
    Asojo OA; Gulnik SV; Afonina E; Yu B; Ellman JA; Haque TS; Silva AM
    J Mol Biol; 2003 Mar; 327(1):173-81. PubMed ID: 12614616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
    Gutiérrez-de-Terán H; Nervall M; Ersmark K; Liu P; Janka LK; Dunn B; Hallberg A; Aqvist J
    Biochemistry; 2006 Sep; 45(35):10529-41. PubMed ID: 16939205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man.
    Li T; Yowell CA; Beyer BB; Hung SH; Westling J; Lam MT; Dunn BM; Dame JB
    Mol Biochem Parasitol; 2004 May; 135(1):101-9. PubMed ID: 15287591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and characterisation of plasmepsin I from Plasmodium falciparum.
    Moon RP; Tyas L; Certa U; Rupp K; Bur D; Jacquet C; Matile H; Loetscher H; Grueninger-Leitch F; Kay J; Dunn BM; Berry C; Ridley RG
    Eur J Biochem; 1997 Mar; 244(2):552-60. PubMed ID: 9119023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis of aspartic protease plasmepsin II complexed with EH58 inhibitor: a QM/MM MD study.
    de Farias Silva N; Lameira J; Alves CN
    J Mol Model; 2011 Oct; 17(10):2631-8. PubMed ID: 21264482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H; Nervall M; Dunn BM; Clemente JC; Aqvist J
    FEBS Lett; 2006 Oct; 580(25):5910-6. PubMed ID: 17045991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum.
    Bhaumik P; Horimoto Y; Xiao H; Miura T; Hidaka K; Kiso Y; Wlodawer A; Yada RY; Gustchina A
    J Struct Biol; 2011 Jul; 175(1):73-84. PubMed ID: 21521654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of plasmepsin II from Plasmodium falciparum in complex with two hydroxyethylamine-based inhibitors.
    Recacha R; Leitans J; Akopjana I; Aprupe L; Trapencieris P; Jaudzems K; Jirgensons A; Tars K
    Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1531-9. PubMed ID: 26625296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor.
    Clemente JC; Govindasamy L; Madabushi A; Fisher SZ; Moose RE; Yowell CA; Hidaka K; Kimura T; Hayashi Y; Kiso Y; Agbandje-McKenna M; Dame JB; Dunn BM; McKenna R
    Acta Crystallogr D Biol Crystallogr; 2006 Mar; 62(Pt 3):246-52. PubMed ID: 16510971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protonation state of the catalytic aspartates in plasmepsin II.
    Friedman R; Caflisch A
    FEBS Lett; 2007 Aug; 581(21):4120-4. PubMed ID: 17689534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses.
    McGillewie L; Soliman ME
    Proteins; 2015 Sep; 83(9):1693-705. PubMed ID: 26146842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting functional residues in Plasmodium falciparum plasmepsins by combining sequence and structural analysis with molecular dynamics simulations.
    Valiente PA; Batista PR; Pupo A; Pons T; Valencia A; Pascutti PG
    Proteins; 2008 Nov; 73(2):440-57. PubMed ID: 18442137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
    Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor.
    Nezami A; Kimura T; Hidaka K; Kiso A; Liu J; Kiso Y; Goldberg DE; Freire E
    Biochemistry; 2003 Jul; 42(28):8459-64. PubMed ID: 12859191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for substrate-based inhibitors fitting the S2' space of malarial aspartic protease plasmepsin II.
    Kiso A; Hidaka K; Kimura T; Hayashi Y; Nezami A; Freire E; Kiso Y
    J Pept Sci; 2004 Nov; 10(11):641-7. PubMed ID: 15568678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallographic evidence for noncoplanar catalytic aspartic acids in plasmepsin II resides in the Protein Data Bank.
    Robbins AH; Dunn BM; Agbandje-McKenna M; McKenna R
    Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):294-6. PubMed ID: 19237752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues.
    Xie D; Gulnik S; Collins L; Gustchina E; Suvorov L; Erickson JW
    Biochemistry; 1997 Dec; 36(51):16166-72. PubMed ID: 9405050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
    Nöteberg D; Hamelink E; Hultén J; Wahlgren M; Vrang L; Samuelsson B; Hallberg A
    J Med Chem; 2003 Feb; 46(5):734-46. PubMed ID: 12593654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flap dynamics of plasmepsin proteases: insight into proposed parameters and molecular dynamics.
    Karubiu W; Bhakat S; McGillewie L; Soliman ME
    Mol Biosyst; 2015 Apr; 11(4):1061-6. PubMed ID: 25630418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.